The blood-cleansing procedure has not been tested on humans yet, but tests with animals have been done and have been successful in showing the procedure is safe, Rae said.

She said the company did not focus on Ebola until recently, after the pathogenesis was released, and an epidemic surfaced in West Africa that has now led to a handful of cases in the United States.

Then, last week, it became known that an infected nurse in Texas was being treated with plasma replacement therapy, which is a different method of blood replacement. The fact other scientists think blood-related treatments might be effective against Ebola supports ImmutriX's scientists' internal belief the firm's technology can help treat people with Ebola.

The company has submitted its technology to the Grand Ebola Challenge, which is an open call from the United States government that will incubate innovative ideas to improve delivery of care and stem the spread of disease. It will feature partnerships for rapid testing and deploying the best solutions to stem the virus.